drugset / Trial / NCT06828874

A Study of Levornidazole Disodium Phosphate for Injection vs. Ornidazole in Treatment of Postoperative Intra-Abdominal Infections Caused by Anaerobic Bacteria

NCT06828874

RandomizedParallel-groupSingle-blindTreatment

Summary

Anaerobic infections are very common in clinical practice. Poor control of anaerobic infections in patients undergoing abdominal surgery may lead to the occurrence of complications. The aim of this study is to explore the efficacy and safety of Levornidazole Phosphate Disodium for Injection in the treatment of patients with postoperative intra-abdominal infections caused by anaerobic bacteria.

Timeline

Start
2023-05-10
Primary completion
2024-09-23
Completion
2024-10-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Levornidazole Unknown 1 g Intravenous
Comparator Ornidazole Other / unclassified 0.5 g Intravenous